ClinicalTrials.gg
Not yet recruitingNCT06642298Updated Oct 15, 2024

Studying Impact of Religiosity and Spirituality on Depression and Anxiety

An observational study in Depression and Anxiety, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-15.

Sponsored by Assiut University · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
52
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to detect correlation between religiosity/spirituality and severity of depression and anxiety as well as finding impact on quality of life in patients, suffering from one of those disorders or both, who are attending the Psychiatric Clinic and Ward of Assiut University Hospitals. Given the centrality of religious activities in Egyptian society and the Arab population as a whole, finding such correlation may be beneficial in terms of analysing factors that may lead to depression and/or anxiety as well as factors that may reduce their severities.

Read the detailed description

Religiosity and spirituality are fundamental aspects of the human experience, shaping beliefs, values, and how individuals navigate life's challenges. Religiosity refers to the degree to which individuals identify with, and participate in the practices and beliefs of, a particular religion. It encompasses behaviors like prayer, attending religious services, and following religious teachings. Spirituality, on the other hand, is a broader concept that reflects a sense of connection to something larger than oneself, a search for meaning and purpose in life. This connection can be expressed through religious beliefs, but it can also be independent of religion, encompassing a connection to nature, humanity, or a sense of purpose. Research has increasingly explored the complex interplay between these constructs and mental health. The relationship between religiosity/spirituality and mental health is multifaceted. Religious involvement can provide individuals with social support, a sense of belonging, and a framework for coping with stress. Spiritual beliefs can offer comfort, hope, and a sense of purpose, potentially promoting resilience in the face of challenges. However, the relationship is not always straightforward. Certain religious beliefs or practices could contribute to feelings of guilt, shame, or isolation, potentially impacting mental health. Additionally, negative religious coping styles, such as feeling angry or abandoned by God, might exacerbate mental health problems. Given the centrality of religion in the Arab world, including Egypt, a deeper look into the associations between religiosity/spirituality and psychiatric disorders such as depression and anxiety is warranted.

02

Conditions studied

  • Depression
  • Anxiety

Keywords

  • Depression
  • Anxiety
  • Religiosity
  • Spirituality
  • Egypt
03

In context

Depression

8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 52 is below the median of 158 across 1,111 observational studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients over the age of 18 diagnosed with depression and/or anxiety who attend the Psychiatry hospital in Assiut University.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age above 18 years old.

    1. Diagnosed with Depression and/or Anxiety disorders according to the DSM-5 criteria.

Exclusion criteria

  1. Severe psychiatric disorders including schizophrenia, personality disorders and drug-use disorders.

    1. Patients with cognitive impairment.
    2. Severe comorbid medical condition or disabilities including metabolic diseases and neurological disabilities.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
52 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Correlation between religiosity/spirituality and severity of depression and/or anxiety.

    Correlation between religiosity/spirituality and severity of depression and/or anxiety. Religiosity/Spirituality measures will include Centrality of Religiosity 5 and the Spiritual Well-Being Scale. Depression and Anxiety severity will be assessed by Hamilton Scale.

    Time frame: 2 years

Secondary outcomes

  1. Quality of Life by WHOQOL-BREF Scale score

    Assessing quality of life by using the The WHO Quality of Life (WHOQOL - BREF) scale, which is a widely used tool for assessing an individual's perceived quality of life across various domains. The Arabic version of this scale is designed to measure the quality of life in Arabic-speaking populations, considering cultural and linguistic differences.

    Time frame: 2 years

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Hill PC, Hood RW. Measures of Religiosity. Birmingham: Religious Education Press; 1999
  • Miller WR, Thoresen CE. Spirituality and Health: What We Know, What We Need to Know. Journal of Behavioral Medicine. 2003;26(1):1-11
  • Pargament KI. The Psychology of Religion and Coping: Theory, Research, Practice. New York: Guilford Press; 1997.
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCIDI), Clinician Version. New York: New York Psychiatric Institute; 1997
  • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967 Dec;6(4):278-96. doi: 10.1111/j.2044-8260.1967.tb00530.x. No abstract available. PubMed 6080235 ↗
  • HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5. doi: 10.1111/j.2044-8341.1959.tb00467.x. No abstract available. PubMed 13638508 ↗
  • Huber S, Huber OW. The Centrality of Religiosity Scale (CRS). Religions. 2012;3(3):710-724
  • Paloutzian RF, Ellison CW. Loneliness, spiritual well-being, and the quality of life. In: K. S. Schaefer & S. S. M. Cohen, editors. Measurement of Meaningful Life. New York: Wiley; 1982. p. 222-233
  • The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998 Jun;46(12):1569-85. doi: 10.1016/s0277-9536(98)00009-4. PubMed 9672396 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06642298
Lead sponsor
Assiut University
Responsible party
Abdelrahman Ahmed Abdelrahman Ali (Principal Investigator, Assiut University) — Principal investigator
First posted
Oct 15, 2024
Start date
Dec 1, 2024 (estimated)
Primary completion
Dec 1, 2025 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Oct 15, 2024

Study contacts

Hossam Ahmed, Prof
Contact
hossamkhalifa71@yahoo.com
+20100062662 37
Mostafa Noaman, Prof
Contact
mostafano3man@yahoo.com
+20109822295 2

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion